Nanofabrication and characterization of some poorly soluble novel anticancer drugs for improvement of oral bioavailability: In vitro, In vivo and ex vivo evaluations

Pharmacology, Toxicology and Pharmaceutical Science

1. Malignant Neoplasm 100%
2. Bioavailability 100%
3. Anticarcinogen 100%
4. Breast Cancer 40%
5. Chemotherapy Regimen 16%
6. Bacterial Infection 12%
7. Nanoparticle 12%
8. Therapeutic Window 12%
9. Emulsifying Agent 12%
10. Chronic Disease 12%
11. Excipient 8%
12. Zeta Potential 8%
13. High Performance Liquid Chromatography 8%
14. Nanoemulsion 8%
15. Diseases 8%
16. Phospholipid 8%
17. Prevalence 8%
18. Adverse Event 8%
19. Rat 8%